首页> 外文期刊>Medicine and Health - Rhode Island >Practical Considerations for Prescribing Benzodiazepines and Opioids
【24h】

Practical Considerations for Prescribing Benzodiazepines and Opioids

机译:处方苯二氮卓类药物和阿片类药物的实际考虑

获取原文
           

摘要

The Food and Drug Administration is responsible for evaluatingand approving the medications we prescribe. The FDAreviews post-market experience and monitors adverse drugreactions or unexpected effects. One of the strictest warningsthe FDA can apply to a medication is a Boxed warningor Black Box warning. “Drugs that have special problems,particularly ones that may lead to death or serious injury,may have this warning information displayed within a boxin the prescribing information. This is often referred to asa “boxed” or “black box” warning. Drugs that have suchboxed warnings are not permitted to have reminder ads.”1In August of 2016, the FDA issued a Black Box warningregarding co-prescribing of benzodiazepines2 and opioids:
机译:美国食品药品监督管理局负责评估和批准我们开出的药物。 FDA审查了上市后的经验并监测药物不良反应或意想不到的影响。 FDA可以对药物使用的最严格的警告之一是Boxed警告或Black Box警告。 “有特殊问题的药物,尤其是可能导致死亡或严重伤害的药物,可以在处方信息的框中显示此警告信息。这通常称为“装箱”或“黑匣子”警告。带有此类加框警告的药物不得带有提醒性广告。” 1 2016年8月,FDA发出了关于并用苯二氮卓类药物2和阿片类药物的黑匣子警告:

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号